Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Arkhipova, Ksenia A ^a   Sheyderman, Anastasia N ^a   Laktionov, Konstantin K ^a   Mochalnikova, Valeria V ^a   Zborovskaya, Irina B ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Caveolin; Flotillin; Non small cell lung cancer; Soft tissue sarcoma; Stomatin

Indexed keywords

CAVEOLIN; FLOTILLIN 1; FLOTILLIN 2; MESSENGER RNA; STOMATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE SARCOMA; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CAVEOLIN 1; DOWN-REGULATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RNA, MESSENGER; SARCOMA; UP-REGULATION; YOUNG ADULT;

EID: 84896712774     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-100     Document Type: Article

References (25)

1. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 1994, 4:231-235. 10.1016/0962-8924(94)90114-7, 14731661.
2. Schulte T, Paschke KA, Laessing U, Lottspeich F, Stuermer CA. Reggie-1 and reggie-2, two cell surface proteins expressed by retinal ganglion cells during axon regeneration. Development 1997, 124:577-587.
3. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207. 10.1038/35025089, 11001060.
4. Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 2006, 8:46-54. 10.1038/ncb1342, 16341206.
5. Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 2004, 64:7361-7369. 10.1158/0008-5472.CAN-04-0823, 15492257.
6. Santamaría A, Castellanos E, Gómez V, Benedit P, Renau-Piqueras J, Morote J, Reventós J, Thomson TM, Paciucci R. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 2005, 25:1900-1911. 10.1128/MCB.25.5.1900-1911.2005, 549350, 15713644.
7. Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J, Song L. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin Cancer Res 2011, 17:3089-3099. 10.1158/1078-0432.CCR-10-3068, 21447726.
8. Zhang PF, Zeng GQ, Hu R, Li C, Yi H, Li MY, Li XH, Qu JQ, Wan XX, He QY, Li JH, Chen Y, Ye X, Li JY, Wang YY, Feng XP, Xiao ZQ. Identification of Flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis. J Proteomics 2012, 77:202-214.
9. Stewart GW, Hepworth-Jones BE, Keen JN, Dash BC, Argent AC, Casimir CM. Isolation of cDNA coding for an ubiquitous membrane protein deficient in high Na+, low K + stomatocytic erythrocytes. Blood 1992, 79:1593-1601.
10. Price MP, Thompson RJ, Eshcol JO, Wemmie JA, Benson CJ. Stomatin modulates gating of acid-sensing ion channels. J Biol Chem 2004, 279:53886-53891. 10.1074/jbc.M407708200, 15471860.
11. Zhang JZ, Hayashi H, Ebina Y, Prohaska R, Ismail-Beigi F. Association of stomatin (band 7.2b) with Glut1 glucose transporter. Arch Biochem Biophys 1999, 372:173-178. 10.1006/abbi.1999.1489, 10562431.
12. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 1999, 274:12702-12709. 10.1074/jbc.274.18.12702, 10212252.
13. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 1997, 272:13793-13802. 10.1074/jbc.272.21.13793, 9153235.
14. Cassoni P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, Volante M, Scagliotti GV, Papotti M. Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases. Histopathology 2009, 55:20-27. 10.1111/j.1365-2559.2009.03326.x, 19614763.
15. Ho CC, Kuo SH, Huang PH, Huang HY, Yang CH, Yang PC. Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. Lung Cancer 2008, 59:105-110. 10.1016/j.lungcan.2007.07.024, 17850918.
16. Yoo SH, Park YS, Kim HR, Sung SW, Kim JH, Shim YS, Lee SD, Choi YL, Kim MK, Chung DH. Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 2003, 42:195-202. 10.1016/S0169-5002(03)00287-3, 14568687.
17. Bayer-Garner I, Morgan M, Smoller BR. Caveolin expression is common among benign and malignant smooth muscle and adipocyte neoplasms. Mod Pathol 2002, 15:1-5. 10.1038/modpathol.3880481, 11796834.
18. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, Schneider U. Down-regulation of Caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001, 158:833-839. 10.1016/S0002-9440(10)64031-X, 1850346, 11238032.
19. Ravid D, Maorb S, Wernerb H, Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv Enzyme Regul 2006, 46:163-175. 10.1016/j.advenzreg.2006.01.022, 16857240.
20. Arkhipova KA, Zborovskaya IB. Microdomain-forming proteins of different families in common signal pathways. Biochem (Moscow) Suppl Series A: Membr Cell Biol 2012, 7:1-11.
21. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 2002, 160:2207-2217. 10.1016/S0002-9440(10)61168-6, 1850810, 12057923.
22. Lu{cyrillic}pez-Casas PP, del Mazo J. Regulation of flotillin-1 in the establishment of NIH-3 T3 cell-cell interactions. FEBS Lett 2003, 555:223-228. 10.1016/S0014-5793(03)01239-0, 14644419.
23. Cao S, Fernandez-Zapico ME, Jin D, Puri V, Cook TA, Lerman LO, Zhu XY, Urrutia R, Shah V. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem 2005, 280:1901-1910.
24. Kathuria H, Cao YX, Ramirez MI, Williams MC. Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ETS proteins in epithelial cell expression. J Biol Chem 2004, 279:30028-30036. 10.1074/jbc.M402236200, 15138262.
25. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36. 10.1093/nar/30.9.e36, 113859, 11972351.